Difficulty: Medium
Average Score: 71%
Practice
When treating a patient who's been taking tricyclic antidepressants for the past three months and has just been prescribed albuterol, a nurse should understand that
Correct answer
C
Rationale
In this scenario, option C is the correct answer because tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs) can increase the risk of tachycardia and angina when taken with beta 2 adrenergic agonists like albuterol. This interaction can lead to cardiovascular complications due to the combined effects on heart rate and blood pressure.
Option A is incorrect because TCAs are more likely to cause tachycardia rather than bradycardia when combined with beta 2 adrenergic agonists. Option B is incorrect as TCAs do not increase the risk of gastric ulcers, and they do not need to be taken with a fatty meal. Option D is incorrect as TCAs are not associated with pulmonary edema leading to peripheral edema and anasarca.
Educationally, understanding drug interactions is crucial for healthcare professionals to ensure safe and effective patient care. This question highlights the importance of recognizing potential adverse effects when combining different classes of medications, emphasizing the need for thorough medication reconciliation and monitoring for drug interactions in clinical practice.
Option A is incorrect because TCAs are more likely to cause tachycardia rather than bradycardia when combined with beta 2 adrenergic agonists. Option B is incorrect as TCAs do not increase the risk of gastric ulcers, and they do not need to be taken with a fatty meal. Option D is incorrect as TCAs are not associated with pulmonary edema leading to peripheral edema and anasarca.
Educationally, understanding drug interactions is crucial for healthcare professionals to ensure safe and effective patient care. This question highlights the importance of recognizing potential adverse effects when combining different classes of medications, emphasizing the need for thorough medication reconciliation and monitoring for drug interactions in clinical practice.